SPL - Starwin Products Limited
Starwin Products Limited is a pharmaceutical manufacturer based in Ghana. It traces its history to 1960 when Sterling Products International, an American pharmaceutical company, incorporated a subsidiary in Ghana. In 1976, the company sold 50% of its stock to a group of Ghanaian investors. The group eventually bought the remaining shares of the company in 1987 and subsequently changed the name to Starwin Products Limited. The company's product line includes Rapinol, Asmadrin, Painoff, Paraking, milk of magnesia and liver salts.
|Last Trading Results||Growth & Valuation|
|Opening Price:||--||Earnings Per Share:||0.0032|
|Day's Low Price:||--||Price/Earning Ratio:||6.20|
|Day's High Price:||--||Dividend Per Share:||0.00|
|Traded Volume:||0||Dividend Yield:||0%|
|Number of Deals:||0||Shares Outstanding:||259.81m|
SPL Stock Market Performance
Starwin Products Limited (SPL) has been delisted from the Ghana Stock Exchange.
Profile of Starwin Products Limited
Starwin Products Limited operates in the Health Care sector. Unfortunately, we do not have information on the company's board of directors and/or key executives at this time.
|Factsheet of Starwin Products Limited|
P. O. Box 5760, Accra-North
SPL Industrial Market Competitors
Starwin Products Limited, issuers of the SPL stock on the Ghana Stock Exchange, have two market competitors who are also engaged in the Health Care sector. The table below gives you an overview of their market standing.
|Code||Name||Mkt. Cap.||L. Price||YearTD|
|DASPHARMA||Dannex Ayrton Starwin Plc||33.91m||0.40||+0.00%|
|IIL||Intravenous Infusions Limited||10.35m||0.04||-20.0%|